DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,747,653 | -16.9% | 381,893 | -19.6% | 0.30% | -7.5% |
| Q2 2023 | $114,001,440 | -5.9% | 475,006 | -1.2% | 0.32% | -11.4% |
| Q1 2023 | $121,181,084 | -2.2% | 480,801 | +2.9% | 0.36% | -9.8% |
| Q4 2022 | $123,966,004 | -4.7% | 467,056 | -7.2% | 0.40% | -3.1% |
| Q3 2022 | $130,042,000 | -15.4% | 503,471 | -17.0% | 0.41% | +2.7% |
| Q2 2022 | $153,742,000 | -14.4% | 606,431 | -1.0% | 0.40% | +7.8% |
| Q1 2022 | $179,640,000 | -17.3% | 612,415 | -7.2% | 0.37% | -11.0% |
| Q4 2021 | $217,132,000 | +9.4% | 659,955 | +1.2% | 0.42% | +1.9% |
| Q3 2021 | $198,460,000 | +9.1% | 651,887 | -3.8% | 0.41% | +9.3% |
| Q2 2021 | $181,916,000 | +18.4% | 677,881 | -0.7% | 0.38% | +14.6% |
| Q1 2021 | $153,622,000 | +7.0% | 682,523 | +5.6% | 0.33% | -1.2% |
| Q4 2020 | $143,605,000 | +0.1% | 646,462 | -3.0% | 0.33% | -7.3% |
| Q3 2020 | $143,520,000 | +17.0% | 666,511 | -3.9% | 0.36% | +5.3% |
| Q2 2020 | $122,684,000 | +34.1% | 693,795 | +5.0% | 0.34% | +11.5% |
| Q1 2020 | $91,460,000 | -19.5% | 660,794 | -10.7% | 0.30% | +7.0% |
| Q4 2019 | $113,605,000 | +1.5% | 740,196 | -4.4% | 0.28% | -7.8% |
| Q3 2019 | $111,884,000 | +9.7% | 774,662 | +8.6% | 0.31% | +8.8% |
| Q2 2019 | $101,970,000 | +11.5% | 713,473 | +3.0% | 0.28% | +9.2% |
| Q1 2019 | $91,472,000 | +44.6% | 692,865 | +12.9% | 0.26% | +26.2% |
| Q4 2018 | $63,272,000 | -13.8% | 613,578 | -9.1% | 0.21% | +1.5% |
| Q3 2018 | $73,359,000 | +11.0% | 675,124 | +0.8% | 0.20% | +6.8% |
| Q2 2018 | $66,061,000 | +0.6% | 669,448 | -0.1% | 0.19% | 0.0% |
| Q1 2018 | $65,642,000 | +7.0% | 670,429 | +1.4% | 0.19% | +13.1% |
| Q4 2017 | $61,364,000 | +8.4% | 661,105 | +0.2% | 0.17% | +0.6% |
| Q3 2017 | $56,608,000 | -5.8% | 659,926 | -7.4% | 0.17% | -13.9% |
| Q2 2017 | $60,124,000 | +20.4% | 712,455 | +22.0% | 0.19% | +0.5% |
| Q1 2017 | $49,957,000 | +18.5% | 584,085 | +7.8% | 0.19% | +6.0% |
| Q4 2016 | $42,158,000 | +13.0% | 541,603 | +13.8% | 0.18% | +23.8% |
| Q3 2016 | $37,300,000 | -5.8% | 475,820 | +21.4% | 0.15% | -8.1% |
| Q2 2016 | $39,591,000 | +0.8% | 391,990 | -5.4% | 0.16% | +3.9% |
| Q1 2016 | $39,295,000 | -1.8% | 414,240 | -3.9% | 0.15% | 0.0% |
| Q4 2015 | $40,032,000 | +5.5% | 431,010 | -3.2% | 0.15% | +5.5% |
| Q3 2015 | $37,947,000 | +96.8% | 445,340 | +97.7% | 0.15% | +114.7% |
| Q2 2015 | $19,280,000 | -50.8% | 225,260 | -51.2% | 0.07% | -50.0% |
| Q1 2015 | $39,169,000 | -3.6% | 461,350 | -2.7% | 0.14% | -2.9% |
| Q4 2014 | $40,625,000 | +19.6% | 473,980 | +6.1% | 0.14% | +13.8% |
| Q3 2014 | $33,958,000 | -2.8% | 446,940 | +0.7% | 0.12% | -2.4% |
| Q2 2014 | $34,951,000 | -24.6% | 443,930 | -28.2% | 0.13% | -28.8% |
| Q1 2014 | $46,380,000 | -2.8% | 618,396 | +0.1% | 0.18% | -3.3% |
| Q4 2013 | $47,701,000 | +9.1% | 617,886 | -2.0% | 0.18% | +1.1% |
| Q3 2013 | $43,717,000 | +1.5% | 630,656 | -7.3% | 0.18% | +0.6% |
| Q2 2013 | $43,055,000 | – | 680,176 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |